drugset / Trial / NCT01046630
Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects
Phase 1
Completed
128 enrolled
AstraZeneca
University of Manchester · collabUniversity of Oxford · collab
RandomizedSingle-groupDouble-blindBasic science
Summary
The purpose of this study is to determine the effect of a single dose infusion of AZD 6765 compared with placebo and ketamine on the blood oxygen level dependent signal using fMRI (functional Magnetic Resonance Imaging) in depressed subjects.
Timeline
- Start
- 2009-12
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketamine | Small molecule | — | Intravenous |
| Subject | lanicemine | Small molecule | — | Intravenous |